1
|
Pum-Im P, Chularojanamontri L, Chantharasamee J. Classic Kaposi sarcoma mimicking cellulitis in a middle-aged Asian man. Australas J Dermatol 2023; 64:e379-e381. [PMID: 37706595 DOI: 10.1111/ajd.14159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Revised: 08/27/2023] [Accepted: 09/03/2023] [Indexed: 09/15/2023]
Affiliation(s)
- Patinya Pum-Im
- Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Leena Chularojanamontri
- Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Jomjit Chantharasamee
- Division of Oncology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
| |
Collapse
|
2
|
Sen F, Tambas M, Ciftci R, Toz B, Kilic L, Bozbey HU, Karanlik H, Kurul S, Vatansever S, Oral EN, Saglam EK, Kizir A, Saip P, Aydiner A. Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma. J DERMATOL TREAT 2015; 27:275-7. [PMID: 26368051 DOI: 10.3109/09546634.2015.1094177] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND Non-HIV related Kaposi sarcoma (NHKS) is a rare indolent neoplasm which is more common around Mediterranean origin. Data concerning factors that influence progression-free survival (PFS) for NHKS are insufficient. The purpose of present retrospective analysis was to distinguish the factors affecting PFS in patients with NHKS. METHODS A hundred and twenty-eight consecutive patients with NHKS who were treated or observed between 1997 and 2014 at Istanbul University Institute of Oncology were included into the study. Treatment response and progression definitions were determined according to different treatment modalities administered at first line. RESULTS Majority of patients were male (n = 97, 75.8%). Median age of the whole group was 66 years (28-85). Of the patients, 15 patients were immunosuppressant, whereas 113 patients had no disease that caused immunosuppression. Patients were treated with local excision (n = 57, 44.5%), chemotherapy (n = 32, 25.0%) and/or radiotherapy (n = 13, 10.2%) or observed without treatment (n = 26, 20.3%). At a median follow-up of 28 months, 71 (55.5%) patients had progression, while 3 patients (2.3%) died of NHKS. On univariate analysis, patients who had hypertension (HT) had poorer PFS compared with others (19 ± 12 versus 41 ± 22 months; p = 0.03), whereas plaque formation was associated with better outcome (25 ± 9 versus 54 ± 12 months; p = 0.03). In addition, heavy smoking (≥40 pack-years) had a borderline significance regarding better PFS time (23 ± 24 versus 45 ± 38 months, p = 0.06). On multivariate analysis, none of factors evaluated had any impact on PFS. CONCLUSIONS HT was correlated with poorer outcome among NHKS patients. Patients with plaque formation and ≥40 pack-years of smoking had better PFS than others.
Collapse
Affiliation(s)
- Fatma Sen
- a Department of Medical Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Makbule Tambas
- b Department of Radiation Oncology , Okmeydani Training and Research Hospital , Istanbul , Turkey
| | - Rumeysa Ciftci
- a Department of Medical Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Bahtiyar Toz
- a Department of Medical Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Leyla Kilic
- a Department of Medical Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Hamza U Bozbey
- a Department of Medical Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Hasan Karanlik
- c Surgical Oncology Unit, Institute of Oncology, Istanbul University , Istanbul , Turkey , and
| | - Sidika Kurul
- c Surgical Oncology Unit, Institute of Oncology, Istanbul University , Istanbul , Turkey , and
| | - Sezai Vatansever
- a Department of Medical Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Ethem N Oral
- d Department of Radiation Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Esra K Saglam
- d Department of Radiation Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Ahmet Kizir
- d Department of Radiation Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Pinar Saip
- a Department of Medical Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| | - Adnan Aydiner
- a Department of Medical Oncology , Institute of Oncology, Istanbul University , Istanbul , Turkey
| |
Collapse
|